Aperçu de la demande d’action collective 500-06-000523-106

Impression de l'aperçu de la demande d'action collective

Étape de la demande :

Autorisation - Jugement sur le désistement

Palais de justice :

Montréal

Date de dépôt de la demande d'autorisation :

2010-09-29

No de dossier :

500-06-000523-106

Sujet :

Responsabilité extracontractuelle; Protection du consommateur; Protection du consommateur

Cette affaire concerne :

Nom des parties :

COLETTE JOLY GOULET vs NOVARTIS PHARMA CANADA INC. and NOVARTIS PHARMACEUTICALS CORP. and NOVARTIS INTERNATIONAL AG and PROCTER & GAMBLE PHARMACEUTICALS CANADA INC. and PROCTER & GAMBLE PHARMACEUTICALS INC. and THE PROCTER & GAMBLE COMPANY and WARNER CHILCOTT CANADA CO. and WARNER CHILCOTT PHARMACEUTICALS INC. and WARNER CHILCOTT PLC

Description du groupe qui intente l'action :

SUB-GROUP A: • All persons in Canada (including their estates, executors, personal representatives, their dependants and family members), who were prescribed, purchased, used or ingested any Bisphosphonate drugs, including but not limited to the brand name Actonel, manufactured, marketed or distributed by Respondents Procter & Gamble Pharmaceuticals Canada Inc., Procter & Gamble Pharmaceuticals Inc., The Procter & Gamble Company, Warner Chilcott Canada Co., Warner Chilcott Pharmaceuticals Inc. and Warner Chilcott PLC and/or any other related companies, or any other Group or Sub-Group to be determined by the Court; SUB-GROUP B: • All persons in Canada (including their estates, executors, personal representatives, their dependants and family members), who were prescribed, purchased, used or ingested any Bisphosphonate drugs, including but not limited to the brand name Aclasta, manufactured, marketed or distributed by Respondents Novartis Pharma Canada Inc., Novartis Pharmaceuticals Corp., Novartis International AG and/or any other related companies, or any other Group or Sub-Group to be determined by the Court;

Documents et actes de procédure :

Document Date du document
Demande d’autorisation d’exercer une action collective 2010-09-29
Réponse 2010-10-29
Jugement sur désistement 2017-01-25
Avis aux membres 2017-01-25

Avocats de la partie demanderesse :

Nom Courriel Téléphone Adresse Nom du cabinet Site web
Chung, Daniel [email protected] (514)842-7776 10 Notre-Dame Est, Suite 200, Montreal, Québec, Canada , H2Y 1B7 Merchant Law Group www.merchantlaw.com

Avocats de la partie défenderesse :

Nom Courriel Téléphone Adresse Nom du cabinet
Durocher, André (514)397-7495 800 Place Victoria, suite 3700 P.O. Box 242, Montréal, Québec, Canada , H4Z 1E9 Fasken Martineau DuMoulin LLP
Saucier, Emmanuelle (514)987-5000 1000 ouest, Sherbrooke, suite 2700, Montréal, Québec, Canada , H3A 3G4 McMillan LLP

Étape de la demande

1 - Autorisation - Jugement sur le désistement

Palais de justice

Montréal

Date de dépôt de la demande d'autorisation

2010-09-29

No de dossier

500-06-000523-106

Sujet

Responsabilité extracontractuelle; Protection du consommateur; Protection du consommateur

Cette affaire concerne

Nom des parties

COLETTE JOLY GOULET vs NOVARTIS PHARMA CANADA INC. and NOVARTIS PHARMACEUTICALS CORP. and NOVARTIS INTERNATIONAL AG and PROCTER & GAMBLE PHARMACEUTICALS CANADA INC. and PROCTER & GAMBLE PHARMACEUTICALS INC. and THE PROCTER & GAMBLE COMPANY and WARNER CHILCOTT CANADA CO. and WARNER CHILCOTT PHARMACEUTICALS INC. and WARNER CHILCOTT PLC

SUB-GROUP A: • All persons in Canada (including their estates, executors, personal representatives, their dependants and family members), who were prescribed, purchased, used or ingested any Bisphosphonate drugs, including but not limited to the brand name Actonel, manufactured, marketed or distributed by Respondents Procter & Gamble Pharmaceuticals Canada Inc., Procter & Gamble Pharmaceuticals Inc., The Procter & Gamble Company, Warner Chilcott Canada Co., Warner Chilcott Pharmaceuticals Inc. and Warner Chilcott PLC and/or any other related companies, or any other Group or Sub-Group to be determined by the Court; SUB-GROUP B: • All persons in Canada (including their estates, executors, personal representatives, their dependants and family members), who were prescribed, purchased, used or ingested any Bisphosphonate drugs, including but not limited to the brand name Aclasta, manufactured, marketed or distributed by Respondents Novartis Pharma Canada Inc., Novartis Pharmaceuticals Corp., Novartis International AG and/or any other related companies, or any other Group or Sub-Group to be determined by the Court;
Retour